In December 2018, PredictImmune launched PredictSURE IBDTM, the world’s first, truly validated and CE-marked prognostic test for guiding treatment options in inflammatory bowel disease (Crohn’s disease and ulcerative colitis). PredictSURE IBDTM is an easy-to-set-up blood-based biomarker test, combined with a sophisticated algorithm to produce a disease risk score.
Guiding IBD treatment options with PredictImmune
Users submit the raw biomarker data, and and receive rapid online test result reporting via a secure web portal, designed and developed by Tier 2 Consulting within a structured project delivery approach, compliant with requirements of the ISO13485 quality standard for medical devices.
“Developing IVD software, compliant with EU and global regulation, in an agile manner is an intensely challenging task. However, with Tier 2 Consulting, we have managed to deliver a user-friendly and regulatory compliant web portal interface solution for our PredictSURE IBDTM test in a very short space of time” - Fionnuala Patterson, PredictImmune Ltd
Tier 2 works in partnership with our customers to understand their business challenges, and deliver custom software solutions using modern, open-source, cloud-native technology and an agile project approach.